Cara Therapeutics' Series A Round

Cara Therapeutics raised a round of funding on December 10, 2004. Investors include Esperante.

Cara Therapeutics is an emerging biotechnology company focused on developing novel therapeutics to treat human diseases associated with pain and inflammation. Cara possesses both near-term clinical de…

Articles about Cara Therapeutics' Series A Round: